Featured Content

The New Renin Antagonist: Aliskiren 2/20/2008

Last year saw the introduction of a direct renin antagonist (RA), the first new class of antihypertensive medications to enter the market in more than a decade.

ALISKIREN

New Drug Review 10/18/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

Advertisement